Literature DB >> 8807703

Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience.

N S Macklon1, I A Greer.   

Abstract

The incidence and pattern of thromboembolic complications in obstetric and gynaecological patients in Scotland between 1981 and 1992 was investigated by analysing ICD coded data retrieved from the SMR1 and SMR2 database. The effect of mode of delivery and maternal age over 35 on risk of thromboembolism in pregnancy was also assessed. 0.076% of gynaecological episodes were subsequently complicated by thromboembolic events. Nineteen percent of those suffering thromboembolic complications within two weeks of discharge were referred back to gynaecology. The incidence of deep venous thrombosis (DVT) in those under 35 years and over 35 years was 0.615/1000 maternities and 1.216/1000 maternities respectively. Respective figures for postnatal DVT were 0.304/1000 and 0.720/1000 and for pulmonary thromboembolism (PTE), 0.108/ 1000 and 0.405/1000. In both age groups, emergency caesarean section was associated with a higher incidence of DVT than elective caesarean section and vaginal delivery.

Entities:  

Mesh:

Year:  1996        PMID: 8807703     DOI: 10.1177/003693309604100305

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  17 in total

1.  Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women.

Authors:  J G Coen van Hasselt; Bruce Green; Glynn A Morrish
Journal:  Pharm Res       Date:  2012-01-13       Impact factor: 4.200

2.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 4.  Thrombolytic therapy in pregnancy.

Authors:  Georg Leonhardt; Charly Gaul; Hubert H Nietsch; Michael Buerke; Ekkehard Schleussner
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 5.  A review of Caesarean section techniques and postoperative thromboprophylaxis at a tertiary hospital.

Authors:  Chang Qi Hester Lau; Tuck Chin Tiffany Wong; Eng Loy Tan; Devendra Kanagalingam
Journal:  Singapore Med J       Date:  2016-04-08       Impact factor: 1.858

6.  The use of thrombolytic therapy in pregnancy.

Authors:  Eric J Gartman
Journal:  Obstet Med       Date:  2013-07-25

Review 7.  Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Authors:  Rebecca Tooher; Simon Gates; Therese Dowswell; Lucy-Jane Davis
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

8.  Venous thromboembolism in pregnancy.

Authors:  Marcelo P Villa-Forte Gomes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

Review 9.  Anticoagulants in pregnancy.

Authors:  Ian A Greer
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

10.  Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case.

Authors:  Satoshi Taniguchi; Ikuo Fukuda; Masahito Minakawa; Ken-Ichi Watanabe; Kazuyuki Daitoku; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.